Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The Christie NHS Foundation Trust
Abramson Cancer Center at Penn Medicine
Barbara Ann Karmanos Cancer Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center